Laurus Labs (BOM:540222) Accounts Payable: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540222 Laurus Labs Ltd BOM:540222
67 GF Score
Price ₹1,799.00
GF Value ₹841.59
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Laurus Labs Accounts Payable?

Laurus Labs BOM:540222 -0.88% 67 Accounts Payable is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:540222 with a GF Score™ of 67/100 and a GF Value™ of ₹841.59 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Laurus Labs's Accounts Payable for the quarter that ended in Jun. 2026 was ₹0 Mil.

Laurus Labs's quarterly Accounts Payable increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹12,521 Mil) but then declined from Mar. 2026 (₹12,521 Mil) to Jun. 2026 (₹0 Mil).

Laurus Labs's annual Accounts Payable declined from Mar. 2024 (₹10,512 Mil) to Mar. 2025 (₹9,585 Mil) but then increased from Mar. 2025 (₹9,585 Mil) to Mar. 2026 (₹12,521 Mil).

Laurus Labs Accounts Payable Historical Data

* Premium members only.

The historical data trend for Laurus Labs's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laurus Labs Accounts Payable Chart

Laurus Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,763.70 7,106.50 10,512.40 9,584.90 12,520.90

Laurus Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 10,143.60 0.00 12,520.90 0.00
BOM:540222
67GF Score
Laurus Labs Ltd BOM:540222
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laurus Labs Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹0 Mil mean?
Laurus Labs (BOM:540222) has a Accounts Payable of ₹0 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Laurus Labs and its competitors.
Is Laurus Labs' Accounts Payable too high?
Laurus Labs' current Accounts Payable is ₹0 Mil. Overall, Laurus Labs has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Laurus Labs' Accounts Payable compare to ZTS?
Laurus Labs' Accounts Payable of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Laurus Labs and its competitors. Laurus Labs's current Accounts Payable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laurus Labs stock overvalued right now?
Based on GuruFocus' analysis, Laurus Labs (BOM:540222) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹841.59, compared to a current price of ₹1,799.00 — trading 113.8% above its estimated fair value. The current Accounts Payable is ₹0 Mil. Laurus Labs' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Laurus Labs (BOM:540222), the current Accounts Payable is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laurus Labs (BOM:540222) Overvalued in 2026?

Based on GuruFocus' analysis, Laurus Labs stock appears to be overvalued. The current stock price of ₹1,799.00 is trading 113.8% above its estimated GF Value™ of ₹841.59. GuruFocus considers Laurus Labs to be Significantly Overvalued.

Key valuation signals for BOM:540222:

  • Accounts Payable: ₹0 Mil
  • GF Value™: ₹841.59 vs. price of ₹1,799.00 (113.8% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the BOM:540222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laurus Labs Business Description

Other Exchanges LAURUSLABS:India
Address Road No.1, Jubilee Hills, Plot No.103, Hyderabad, TG, IND, 500033
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceutical ingredients (API) including intermediates, Generic Finished dosage forms (FDF), and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, and proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. The company generates revenue from the sale of API, Intermediates and Formulations, Contract research services, and others.
67GF Score

Get the complete analysis for BOM:540222

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,799.00
Price
₹841.59
GF Value